Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients

Katarzyna Kiwerska1, Małgorzata Rydzanicz, Andrzej Kram

  • 1Department of Environmental Mutagenesis, Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland. kassz@man.poznan.pl

Insights

The CDKN2A gene, crucial for cell cycle regulation, is often inactivated in larynx cancer. This study identified frequent mutations in specific codons of CDKN2A, suggesting they are critical hotspots in larynx carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The CDKN2A gene plays a vital role in regulating the cell cycle.
  • Inactivation of CDKN2A contributes to uncontrolled cell proliferation and is implicated in various human malignancies, including larynx cancer.

Purpose of the Study:

  • To investigate mutations within exon 1 and exon 2 of the CDKN2A gene in a cohort of laryngeal cancer patients.
  • To identify novel alterations and recurring mutation hotspots within the CDKN2A gene associated with larynx carcinogenesis.

Main Methods:

  • Genomic DNA was extracted from 390 laryngeal cancer samples.
  • Exons 1 and 2 of the CDKN2A gene were analyzed for mutations using sequencing techniques.

Main Results:

  • A total of 40 distinct CDKN2A alterations were identified in 17% of the laryngeal cancer samples, with a significant proportion being novel.
  • Specific mutations, including transversions at codon 108 (Asp108His, Asp108Tyr) and a transition at codon 110 (Trp110X), were found with notable frequency.
  • These frequently mutated codons are located within ankyrin repeat structures, indicating potential functional significance.

Conclusions:

  • The study identified several novel and recurrent mutations in the CDKN2A gene in laryngeal cancer.
  • Codons 108 and 110 within the CDKN2A gene appear to be critical hotspots for mutations in larynx carcinogenesis, suggesting their importance in tumor development.